Two Sigma Advisers’s Stealth BioTherapeutics Corp. ADS MITO Stock Holding History

Two Sigma Advisers’s Portfolio MITO Stock Details MITO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-13,700	Closed	-$4K	–	2780
2022 Q3	$4K	Sell	13,700 -1,700	-11%	-$484	﹤0.01%	2507
2022 Q2	$4K	Sell	15,400 -1,000	-6%	-$344	﹤0.01%	2613
2022 Q1	$11K	Sell	16,400 -8,800	-35%	-$5.95K	﹤0.01%	2698
2021 Q4	$21K	Sell	25,200 -200	-0.8%	-$209	﹤0.01%	2545
2021 Q3	$35K	Buy	25,400 +2,700	+12%	+$3.66K	﹤0.01%	2391
2021 Q2	$35K	Buy	+22,700	New	+$31.7K	﹤0.01%	2395

Two Sigma Advisers's MITO Position: Q4 2022 in Review

Two Sigma Advisers sold out of Stealth BioTherapeutics Corp. ADS (MITO) in Q4 2022, closing a stake of 13,700 shares — an estimated $4K sold.

Two Sigma Advisers first reported a position in MITO in Q2 2021 and held it in 6 quarters. The position peaked at $35K in Q3 2021. 0 funds tracked by Wall St. Rank hold MITO as of Q4 2022.

Two Sigma Advisers reported no remaining Stealth BioTherapeutics Corp. ADS position as of Q4 2022 after selling out during the quarter.
Two Sigma Advisers sold 13,700 Stealth BioTherapeutics Corp. ADS shares in Q4 2022, an estimated $4K.
Two Sigma Advisers first reported a position in Stealth BioTherapeutics Corp. ADS in Q2 2021 and held it in 6 quarters.
Two Sigma Advisers's Stealth BioTherapeutics Corp. ADS position peaked at $35K in Q3 2021.
0 funds tracked by Wall St. Rank held Stealth BioTherapeutics Corp. ADS as of Q4 2022.

Based on Two Sigma Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.